Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
暂无分享,去创建一个
[1] E Froehlich,et al. Dendrimers bind human serum albumin. , 2009, The journal of physical chemistry. B.
[2] Michael J Sailor,et al. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. , 2008, Angewandte Chemie.
[3] J. Weinstein,et al. Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. , 1980, Journal of lipid research.
[4] R. Juliano,et al. Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. , 1982, Biochimica et biophysica acta.
[5] Ick Chan Kwon,et al. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[6] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[7] L. Kobzik,et al. Lung macrophage uptake of unopsonized environmental particulates. Role of scavenger-type receptors. , 1995, Journal of immunology.
[8] Ralph Weissleder,et al. Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. , 2002, Academic radiology.
[9] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[10] Robert Langer,et al. Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. , 2009, Biomaterials.
[11] Hideyoshi Harashima,et al. Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes , 1994, Pharmaceutical Research.
[12] J. Brash,et al. Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma. , 2001, Biochimica et biophysica acta.
[13] Thomas Vorup-Jensen,et al. Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation , 2010, The Journal of Immunology.
[14] Karl Fischer,et al. Evaluation of nanoparticle aggregation in human blood serum. , 2010, Biomacromolecules.
[15] Ronald J Moore,et al. Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. , 2004, Analytical chemistry.
[16] Isabelle Raynal,et al. Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10 , 2004, Investigative radiology.
[17] G. Borchard,et al. The Role of Serum Complement on the Organ Distribution of Intravenously Administered Poly (methyl methacrylate) Nanoparticles: Effects of Pre-Coating with Plasma and with Serum Complement , 1996, Pharmaceutical Research.
[18] Ruth Nussinov,et al. Nanoparticle-induced vascular blockade in human prostate cancer. , 2010, Blood.
[19] T. Fujita,et al. The lectin‐complement pathway – its role in innate immunity and evolution , 2004, Immunological reviews.
[20] I. Maridonneau-Parini,et al. The human macrophage mannose receptor is not a professional phagocytic receptor , 2005, Journal of leukocyte biology.
[21] D. Falcone. Fluorescent Opsonization Assay: Binding of Plasma Fibronectin to Fibrin‐Derivatized Fluorescent Particles Does Not Enhance Their Uptake by Macrophages , 1986, Journal of leukocyte biology.
[22] Iseult Lynch,et al. What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.
[23] K. Williams,et al. Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. , 1989, The Journal of biological chemistry.
[24] F M Muggia,et al. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] D. Devine,et al. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. , 1998, Archives of biochemistry and biophysics.
[26] Sara Linse,et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.
[27] W. J. Duncanson,et al. ApJ, in press , 1999 .
[28] R. Müller,et al. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. , 2005, International journal of pharmaceutics.
[29] R. Müller,et al. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] Janos Szebeni,et al. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. , 2005, Toxicology.
[31] T. Rabilloud. Two‐dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains , 2002, Proteomics.
[32] Y. Kurihara,et al. Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. , 1993, The Journal of biological chemistry.
[33] S. Davis,et al. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.
[34] P. Couvreur,et al. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2‐DE, CE and Protein Lab‐on‐chip® system , 2007, Electrophoresis.
[35] Warren C W Chan,et al. Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.
[36] J. Chen,et al. Blood compatibility of polyamidoamine dendrimers and erythrocyte protection. , 2010, Journal of biomedical nanotechnology.
[37] P. Cullis,et al. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. , 1998, Advanced drug delivery reviews.
[38] V. Kolb‐Bachofen. Uptake of toxic silica particles by isolated rat liver macrophages (Kupffer cells) is receptor mediated and can be blocked by competition. , 1992, The Journal of clinical investigation.
[39] J. Kamps,et al. The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse. , 2005, Biochemical and biophysical research communications.
[40] A. Klippel,et al. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium , 2006, Gene Therapy.
[41] B. Pati,et al. Colorimetric assay method for determination of the tannin acyl hydrolase (EC 3.1.1.20) activity. , 2001, Analytical biochemistry.
[42] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[43] L. Vroman,et al. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. , 1980, Blood.
[44] G. Kenner,et al. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. , 2007, Biochimica et biophysica acta.
[45] H. Merkle,et al. Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells. , 2003, Biomaterials.
[46] S. Mineishi,et al. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Sara Linse,et al. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. , 2007, Advances in colloid and interface science.
[48] Y. Barenholz,et al. The Role of Organ Vascularization and Lipoplex-Serum Initial Contact in Intravenous Murine Lipofection* , 2003, Journal of Biological Chemistry.
[49] C. Allen,et al. Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[50] P. Cullis,et al. β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of "Non-self" Particles (*) , 1995, The Journal of Biological Chemistry.
[51] M. Kamihira,et al. Protamine-modified DDAB lipid vesicles promote gene transfer in the presence of serum. , 2001, Journal of biochemistry.
[52] V. Kolb-Bachofen,et al. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. , 1993, Biochimica et biophysica acta.
[53] M. Morandi,et al. Nanoparticle‐induced platelet aggregation and vascular thrombosis , 2005, British journal of pharmacology.
[54] S. Davis,et al. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. , 1993, Biochimica et biophysica acta.
[55] Nancy A Monteiro-Riviere,et al. Mechanisms of quantum dot nanoparticle cellular uptake. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[56] A. Curtis,et al. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. , 2004, Biomaterials.
[57] Benoit Nemery,et al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. , 2002, American journal of respiratory and critical care medicine.
[58] C. Hunt,et al. Murine plasma fibronectin depletion after intravenous injection of liposomes , 1987 .
[59] Esther H Chang,et al. Does a targeting ligand influence nanoparticle tumor localization or uptake? , 2008, Trends in biotechnology.
[60] John W. Earl,et al. Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases , 2007, European Journal of Clinical Pharmacology.
[61] P. S. Appukuttan,et al. Dextran-binding human plasma antibody recognizes bacterial and yeast antigens and is inhibited by glucose concentrations reached in diabetic sera. , 2003, Molecular immunology.
[62] Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. , 1992, Blood.
[63] Ji-Ho Park,et al. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. , 2009, Biomaterials.
[64] V. Torchilin,et al. Which polymers can make nanoparticulate drug carriers long-circulating? , 1995 .
[65] P. Dubin,et al. Binding of bovine serum albumin to heparin determined by turbidimetric titration and frontal analysis continuous capillary electrophoresis. , 2001, Analytical biochemistry.
[66] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[67] T. Yen,et al. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug , 2010, Nanotechnology.
[68] Iseult Lynch,et al. Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.
[69] S. Gordon,et al. Scavenger receptors: diverse activities and promiscuous binding of polyanionic ligands. , 1998, Chemistry & biology.
[70] Mark E. Davis,et al. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.
[71] J. Kamps,et al. Receptor versus non-receptor mediated clearance of liposomes. , 1998, Advanced drug delivery reviews.
[72] R. Weissleder,et al. Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages , 1997, Journal of magnetic resonance imaging : JMRI.
[73] F M Muggia,et al. Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. , 1998, Journal of the National Cancer Institute.
[74] H. Harashima,et al. Identification of proteins mediating clearance of liposomes using a liver perfusion system. , 1998, Advanced drug delivery reviews.
[75] M. Dobrovolskaia,et al. Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.
[76] Mitsuru Hashida,et al. Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. , 2007, International journal of pharmaceutics.
[77] Michael V Sefton,et al. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. , 2004, Biomaterials.
[78] T. Veenstra,et al. The Human Plasma Proteome , 2004, Molecular & Cellular Proteomics.
[79] D. V. Von Hoff,et al. A Phase II Trial of DaunoXome, Liposome‐ Encapsulated Daunorubicin, in Patients with Metastatic Adenocarcinoma of the Colon , 1994, American journal of clinical oncology.
[80] Darren J. Martin,et al. Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.
[81] M. Hashida,et al. Important role of serum proteins associated on the surface of particles in their hepatic disposition. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[82] J. E. Doran,et al. A Critical Assessment of Fibronectin's Opsonic Role for Bacteria and Microaggregates , 1983, Vox sanguinis.
[83] R. Müller,et al. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. , 2005, Biomaterials.
[84] D. Scherman,et al. Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation time. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[85] B. Nemery,et al. Acute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge , 2008, Environmental health perspectives.
[86] R. Müller,et al. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. , 2000, International journal of pharmaceutics.
[87] I. Schousboe. beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. , 1985, Blood.
[88] V. Werth,et al. Intravenously Administered Lecithin Liposomes: A Synthetic Antiatherogenic Lipid Particle , 2015, Perspectives in biology and medicine.
[89] P. Cullis,et al. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. , 1992, The Journal of biological chemistry.
[90] R. Müller,et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.
[91] Rassoul Dinarvand,et al. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. , 2008, International journal of pharmaceutics.
[92] P Couvreur,et al. In vitro evaluation of nanoparticles spleen capture. , 1999, Life sciences.
[93] R. Weissleder,et al. Hybrid PET-optical imaging using targeted probes , 2010, Proceedings of the National Academy of Sciences.
[94] A. Bangham,et al. NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. , 1964, Journal of molecular biology.
[95] W. Goldman,et al. Fungal stealth technology. , 2008, Trends in immunology.
[96] G. Scherphof,et al. The role of beta2-glycoprotein I in liposome-hepatocyte interaction. , 2004, Biochimica et biophysica acta.
[97] Parag Aggarwal,et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.
[98] S. Moghimi,et al. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol‐rich liposomes , 1988, FEBS letters.
[99] M. Benet,et al. Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[100] Kwangmeyung Kim,et al. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[101] H. Tsukada,et al. Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. , 1996, Biochimica et biophysica acta.
[102] H. Iwata,et al. Complement activation by polymers carrying hydroxyl groups. , 2009, ACS applied materials & interfaces.
[103] S Gordon,et al. Macrophage receptors and immune recognition. , 2005, Annual review of immunology.
[104] R. Gurny,et al. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. , 1995, Life sciences.
[105] J. Brash,et al. Identification of apolipoprotein A-I as a major adsorbate on biomaterial surfaces after blood or plasma contact. , 2002, Biomaterials.
[106] P. Legrand,et al. Polyester-Poly(Ethylene Glycol) Nanoparticles Loaded with the Pure Antiestrogen RU 58668: Physicochemical and Opsonization Properties , 2003, Pharmaceutical Research.
[107] T. Ishida,et al. Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[108] Michael J Sailor,et al. Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. , 2009, Small.
[109] H. Sano,et al. A novel type of binding specificity to phospholipids for rat mannose‐binding proteins isolated from serum and liver , 1997, FEBS letters.
[110] Jack F Douglas,et al. Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.
[111] S. Nagata,et al. Identification of Tim4 as a phosphatidylserine receptor , 2007, Nature.
[112] Barbara Klajnert,et al. Haemolytic activity of polyamidoamine dendrimers and the protective role of human serum albumin , 2010, Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[113] K. Mattison,et al. Complex Formation between Bovine Serum Albumin and Strong Polyelectrolytes: Effect of Polymer Charge Density , 1998 .
[114] J. Ruysschaert,et al. Identification of human plasma proteins that bind to cationic lipid/DNA complex and analysis of their effects on transfection efficiency: implications for intravenous gene transfer. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[115] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[116] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[117] K. Higaki,et al. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. , 2007, International journal of pharmaceutics.
[118] D Needham,et al. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. , 1992, Biochimica et biophysica acta.
[119] A. Maitra,et al. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. , 2000, International journal of pharmaceutics.
[120] S. K. Sundaram,et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[121] S Moein Moghimi,et al. Complement: alive and kicking nanomedicines. , 2009, Journal of biomedical nanotechnology.
[122] Michael J Sailor,et al. Biomimetic amplification of nanoparticle homing to tumors , 2007, Proceedings of the National Academy of Sciences.
[123] Rainer H Müller,et al. Functional groups on polystyrene model nanoparticles: influence on protein adsorption. , 2003, Journal of biomedical materials research. Part A.